Search Immortality Topics:



Crinetics Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Posted: August 13, 2022 at 1:57 am

Paltusotine’s Phase 3 PATHFNDR Program in Acromegaly and Phase 2 Program in Carcinoid Syndrome Remain on Track for Top-Line Data in 2023

Link:
Crinetics Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Recommendation and review posted by Fredricko